|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q57010891
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000044.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q57010891
|
|
024
|
|
|
‡a
0000-0002-5925-6452
‡2
orcid
|
|
024
|
|
|
‡a
7406489754
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q57010891
|
|
100
|
0 |
|
‡a
Ronald Anderson
‡c
researcher
‡9
en
|
|
400
|
0 |
|
‡a
Ronald Anderson
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's A 10 years audit of cardiothoracic referrals from a pulmonology service in a developing country: impact of patient human immunodeficiency virus status
|
|
670
|
|
|
‡a
Author's A peroxidase-independent method for the quantitation of extracellular hydrogen peroxide generated by activated phagocytes in vitro
|
|
670
|
|
|
‡a
Author's Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease
|
|
670
|
|
|
‡a
Author's Activation of human neutrophils with chemotactic peptide, opsonized zymosan and the calcium ionophore A23187, but not with a phorbol ester, is accompanied by efflux and store-operated influx of calcium
|
|
670
|
|
|
‡a
Author's Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation.
|
|
670
|
|
|
‡a
Author's Acute phase proteins and stress hormone responses in patients with newly diagnosed active pulmonary tuberculosis.
|
|
670
|
|
|
‡a
Author's ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
|
|
670
|
|
|
‡a
Author's Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669.
|
|
670
|
|
|
‡a
Author's An in vitro assessment of certain cellular and humoral immune functions in patients with chronic acne. Improved leukocyte function and moderate clinical improvement following propranolol therapy in an uncontrolled trial
|
|
670
|
|
|
‡a
Author's An in vitro comparison of the effects of the prooxidative riminophenazines clofazimine and B669 on neutrophil phospholipase A2 activity and superoxide generation
|
|
670
|
|
|
‡a
Author's An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent
|
|
670
|
|
|
‡a
Author's An in vitro investigation of the bioactivities of ciprofloxacin and the new fluoroquinolone agents clinafloxacin
|
|
670
|
|
|
‡a
Author's An in vitro investigation of the bioactivities of ciprofloxacin and the new fluoroquinolone agents clinafloxacin (CI-960) and PD 131628 against Mycobacterium tuberculosis in human macrophages.
|
|
670
|
|
|
‡a
Author's An in vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin, and erythromycin for Staphylococcus aureus
|
|
670
|
|
|
‡a
Author's An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin
|
|
670
|
|
|
‡a
Author's An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent
|
|
670
|
|
|
‡a
Author's An objective filter-based, enzymatic method for the in vivo measurement of the migration of human polymorphonuclear leucocytes
|
|
670
|
|
|
‡a
Author's Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A.
|
|
670
|
|
|
‡a
Author's Antibiotic resistance of pathogens causing community-acquired pneumonia.
|
|
670
|
|
|
‡a
Author's Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids
|
|
670
|
|
|
‡a
Author's Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases.
|
|
670
|
|
|
‡a
Author's Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes
|
|
670
|
|
|
‡a
Author's Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils
|
|
670
|
|
|
‡a
Author's Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes
|
|
670
|
|
|
‡a
Author's Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers.
|
|
670
|
|
|
‡a
Author's Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669
|
|
670
|
|
|
‡a
Author's Bacteraemic pneumococcal pneumonia: current therapeutic options
|
|
670
|
|
|
‡a
Author's Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus.
|
|
670
|
|
|
‡a
Author's Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune System
|
|
670
|
|
|
‡a
Author's Benoxaprofen: a pro-oxidant anti-inflammatory drug?
|
|
670
|
|
|
‡a
Author's Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C.
|
|
670
|
|
|
‡a
Author's Benoxaprofen activation of suppressor activity in mononuclear leucocytes by a pro-oxidative mechanism in vitro
|
|
670
|
|
|
‡a
Author's Biochemical mechanisms of hydrogen peroxide- and hypochlorous acid-mediated inhibition of human mononuclear leukocyte functions in vitro: protection and reversal by anti-oxidants.
|
|
670
|
|
|
‡a
Author's Calcium-dependent potentiation of the pro-inflammatory functions of human neutrophils by tigecycline in vitro
|
|
670
|
|
|
‡a
Author's Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
|
|
670
|
|
|
‡a
Author's Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia
|
|
670
|
|
|
‡a
Author's CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils
|
|
670
|
|
|
‡a
Author's Changes in neutrophil motility accompanying dapsone and rifampicin therapy
|
|
670
|
|
|
‡a
Author's Changes in serum cytokines after repeated bouts of downhill running.
|
|
670
|
|
|
‡a
Author's Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
|
|
670
|
|
|
‡a
Author's Cigarette smoke condensate attenuates phorbol ester-mediated neutrophil extracellular trap formation
|
|
670
|
|
|
‡a
Author's Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E, and tissue injury
|
|
670
|
|
|
‡a
Author's Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems.
|
|
670
|
|
|
‡a
Author's Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
|
|
670
|
|
|
‡a
Author's Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection.
|
|
670
|
|
|
‡a
Author's Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis
|
|
670
|
|
|
‡a
Author's Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
|
|
670
|
|
|
‡a
Author's Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro
|
|
670
|
|
|
‡a
Author's Clofazimine and B669 inhibit the proliferative responses and Na+, K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism.
|
|
670
|
|
|
‡a
Author's Clofazimine-mediated regulation of human polymorphonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness
|
|
670
|
|
|
‡a
Author's Clofazimine-mediated stimulation of prostaglandin synthesis and free radical production as novel mechanisms of drug-induced immunosuppression
|
|
670
|
|
|
‡a
Author's Clofazimine reverses the inhibitory effect of Mycobacterium tuberculosis derived factors on phagocyte intracellular killing mechanisms.
|
|
670
|
|
|
‡a
Author's Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
|
|
670
|
|
|
‡a
Author's Community-acquired pneumonia: still a major burden of disease.
|
|
670
|
|
|
‡a
Author's Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
|
|
670
|
|
|
‡a
Author's Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients
|
|
670
|
|
|
‡a
Author's Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
|
|
670
|
|
|
‡a
Author's Comparison of the pro-oxidative interactions of flunoxaprofen and benoxaprofen with human polymorphonuclear leucocytes in vitro
|
|
670
|
|
|
‡a
Author's Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
|
|
670
|
|
|
‡a
Author's Controversies in the treatment of pneumococcal community-acquired pneumonia.
|
|
670
|
|
|
‡a
Author's Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials
|
|
670
|
|
|
‡a
Author's Counteracting effects of NADPH oxidase and the Na+/Ca2+ exchanger on membrane repolarisation and store-operated uptake of Ca2+ by chemoattractant-activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function
|
|
670
|
|
|
‡a
Author's Defective neutrophil motility in children with measles
|
|
670
|
|
|
‡a
Author's Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole
|
|
670
|
|
|
‡a
Author's Dichloromethane extract of Dicerocaryum senecioides leaves exhibits remarkable anti-inflammatory activity in human T-lymphocytes.
|
|
670
|
|
|
‡a
Author's Differentiation of Human Monocytes in Vitro Following Exposure to Canova in the Absence of Cytokines
|
|
670
|
|
|
‡a
Author's Dithranol-mediated, dose-dependent priming and activation of luminol-enhanced chemiluminescence responses of human neutrophils in vitro.
|
|
670
|
|
|
‡a
Author's Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation.
|
|
670
|
|
|
‡a
Author's Docosahexaenoic acid and eicosapentaenoic acid antagonize the proinflammatory interactions of pneumolysin with human neutrophils
|
|
670
|
|
|
‡a
Author's Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Effect of smoking on acute phase reactants, stress hormone responses and vitamin C in pulmonary tuberculosis.
|
|
670
|
|
|
‡a
Author's Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro.
|
|
670
|
|
|
‡a
Author's Effects of Cigarette Smoke Condensate on Growth and Biofilm Formation by Mycobacterium tuberculosis
|
|
670
|
|
|
‡a
Author's Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin
|
|
670
|
|
|
‡a
Author's Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy
|
|
670
|
|
|
‡a
Author's Effects of clofazimine analogues and tumor necrosis factor- Alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro
|
|
670
|
|
|
‡a
Author's Effects of clofazimine on planktonic and biofilm growth of Mycobacterium tuberculosis and Mycobacterium smegmatis.
|
|
670
|
|
|
‡a
Author's Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis.
|
|
670
|
|
|
‡a
Author's Effects of erythromycin on cellular and humoral immune functions in vitro and in vivo
|
|
670
|
|
|
‡a
Author's Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.
|
|
670
|
|
|
‡a
Author's Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
|
|
670
|
|
|
‡a
Author's Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium.
|
|
670
|
|
|
‡a
Author's Enhanced release of elastase and oxidative inactivation of Alpha -1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine
|
|
670
|
|
|
‡a
Author's Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro
|
|
670
|
|
|
‡a
Author's Epidemiology, virulence factors and management of the pneumococcus
|
|
670
|
|
|
‡a
Author's Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a
|
|
670
|
|
|
‡a
Author's Exposure of a 23F serotype strain of Streptococcus pneumoniae to cigarette smoke condensate is associated with selective upregulation of genes encoding the two-component regulatory system 11 (TCS11).
|
|
670
|
|
|
‡a
Author's Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.
|
|
670
|
|
|
‡a
Author's Expression of the Genes Encoding the Trk and Kdp Potassium Transport Systems of Mycobacterium tuberculosis during Growth In Vitro
|
|
670
|
|
|
‡a
Author's Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia.
|
|
670
|
|
|
‡a
Author's Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
|
|
670
|
|
|
‡a
Author's Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis.
|
|
670
|
|
|
‡a
Author's Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine
|
|
670
|
|
|
‡a
Author's HIV-associated bacterial pneumonia.
|
|
670
|
|
|
‡a
Author's HIV-related pneumococcal disease prevention in adults.
|
|
670
|
|
|
‡a
Author's HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis pati
|
|
670
|
|
|
‡a
Author's Human neutrophil NADPH-oxidase activity is inhibited by lazaroids
|
|
670
|
|
|
‡a
Author's Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium.
|
|
670
|
|
|
‡a
Author's Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants
|
|
670
|
|
|
‡a
Author's Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes
|
|
670
|
|
|
‡a
Author's Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.
|
|
670
|
|
|
‡a
Author's Impact of HIV infection and smoking on lung immunity and related disorders.
|
|
670
|
|
|
‡a
Author's In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy
|
|
670
|
|
|
‡a
Author's In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
|
|
670
|
|
|
‡a
Author's In vitro stimulation of neutrophil motility by metoprolol and sotalol related to inhibition of both H2O2 production and peroxidase mediated iodination of the cell and leucoattractant
|
|
670
|
|
|
‡a
Author's In vivo effects of propranolol on some cellular and humoral immune functions in a group of patients with lepromatous leprosy
|
|
670
|
|
|
‡a
Author's Inactivation of poly
|
|
670
|
|
|
‡a
Author's Inactivation of poly (ADP-ribose) polymerase by hypochlorous acid
|
|
670
|
|
|
‡a
Author's Increased frequency of oxidant-mediated DNA strand breaks in mononuclear leucocytes exposed to activated neutrophils from cigarette smokers.
|
|
670
|
|
|
‡a
Author's Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers
|
|
670
|
|
|
‡a
Author's Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.
|
|
670
|
|
|
‡a
Author's Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice
|
|
670
|
|
|
‡a
Author's Inhibition of mitogen-activated proliferation of human lymphocytes by hypochlorous acid in vitro: protection and reversal by ascorbate and cysteine
|
|
670
|
|
|
‡a
Author's Inhibition of polymorphonuclear leucocyte motility by benoxaprofen related to activation of cellular oxidative metabolism
|
|
670
|
|
|
‡a
Author's Inhibition of the pro-oxidant effects of benoxaprofen on polymorphonuclear leucocytes by retinol acetate in vitro
|
|
670
|
|
|
‡a
Author's Inositol 1,4,5-triphosphate-mediated shuttling between intracellular stores and the cytosol contributes to the sustained elevation in cytosolic calcium in FMLP-activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Investigation into the relationship between calyculin A-mediated potentiation of NADPH oxidase activity and inhibition of store-operated uptake of calcium by human neutrophils.
|
|
670
|
|
|
‡a
Author's Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers.
|
|
670
|
|
|
‡a
Author's Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin
|
|
670
|
|
|
‡a
Author's Investigation of the relationships between plasma levels of ascorbate, vitamin E and beta-carotene and the frequency of sister-chromatid exchanges and release of reactive oxidants by blood leucocytes from cigarette smokers
|
|
670
|
|
|
‡a
Author's Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes.
|
|
670
|
|
|
‡a
Author's Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4
|
|
670
|
|
|
‡a
Author's Leucocyte function in children with kwashiorkor
|
|
670
|
|
|
‡a
Author's Manganese promotes increased formation of hydrogen peroxide by activated human macrophages and neutrophils in vitro
|
|
670
|
|
|
‡a
Author's Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
|
|
670
|
|
|
‡a
Author's Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils
|
|
670
|
|
|
‡a
Author's Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
|
|
670
|
|
|
‡a
Author's Montelukast: more than a cysteinyl leukotriene receptor antagonist?
|
|
670
|
|
|
‡a
Author's Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.
|
|
670
|
|
|
‡a
Author's NADPH-oxidase activity of stimulated neutrophils is markedly increased by serum
|
|
670
|
|
|
‡a
Author's Neutrophils potentiate platinum-mediated injury to human ciliated epithelium in vitro
|
|
670
|
|
|
‡a
Author's New insights into pneumococcal disease.
|
|
670
|
|
|
‡a
Author's Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line.
|
|
670
|
|
|
‡a
Author's Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.
|
|
670
|
|
|
‡a
Author's Oxidant-mediated ciliary dysfunction in human respiratory epithelium
|
|
670
|
|
|
‡a
Author's Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganese in vitro.
|
|
670
|
|
|
‡a
Author's Oxidative inhibition of polymorphonuclear leukocyte motility mediated by the peroxidase/H2O2/halide system: studies on the reversible nature of the inhibition and mechanism of protection of migratory responsiveness by ascorbate, levamisole, thiamine
|
|
670
|
|
|
‡a
Author's Palladium attenuates the pro-inflammatory interactions of C5a, interleukin-8 and pneumolysin with human neutrophils.
|
|
670
|
|
|
‡a
Author's Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics
|
|
670
|
|
|
‡a
Author's Pharmacological approaches to regulate neutrophil activity.
|
|
670
|
|
|
‡a
Author's Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients.
|
|
670
|
|
|
‡a
Author's Plasma levels of beta-carotene are inversely correlated with circulating neutrophil counts in young male cigarette smokers
|
|
670
|
|
|
‡a
Author's Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro
|
|
670
|
|
|
‡a
Author's Pneumolysin activates neutrophil extracellular trap formation
|
|
670
|
|
|
‡a
Author's Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro.
|
|
670
|
|
|
‡a
Author's Pneumolysin as a potential therapeutic target in severe pneumococcal disease.
|
|
670
|
|
|
‡a
Author's Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils.
|
|
670
|
|
|
‡a
Author's Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid.
|
|
670
|
|
|
‡a
Author's Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro
|
|
670
|
|
|
‡a
Author's Pneumolysin Mediates Platelet Activation In Vitro
|
|
670
|
|
|
‡a
Author's Pneumolysin potentiates oxidative inactivation of Alpha -1-proteinase inhibitor by activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Pneumolysin potentiates production of prostaglandin E
|
|
670
|
|
|
‡a
Author's Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils
|
|
670
|
|
|
‡a
Author's Pneumonia as a systemic illness.
|
|
670
|
|
|
‡a
Author's Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation.
|
|
670
|
|
|
‡a
Author's Potentiation of the generation of reactive oxidants by human phagocytes during exposure to benoxaprofen and ultraviolet radiation in vitro.
|
|
670
|
|
|
‡a
Author's Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and
|
|
670
|
|
|
‡a
Author's Prevention of peroxidase mediated inhibition of neutrophil motility and lymphocyte transformation by levamisole, OMPI, sodium aurothiomalate, indomethacin and tolmetin in vitro
|
|
670
|
|
|
‡a
Author's Pro-oxidative interactions of cobalt with human neutrophils
|
|
670
|
|
|
‡a
Author's Pro-oxidative interactions of dithranol with human phagocytes promote oxidative damage to DNA of bystander leucocytes
|
|
670
|
|
|
‡a
Author's Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer
|
|
670
|
|
|
‡a
Author's Proinflammatory interactions of pneumolysin with human neutrophils.
|
|
670
|
|
|
‡a
Author's Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.
|
|
670
|
|
|
‡a
Author's Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C
|
|
670
|
|
|
‡a
Author's Reactive oxidants regulate membrane repolarization and store-operated uptake of calcium by formyl peptide-activated human neutrophils.
|
|
670
|
|
|
‡a
Author's Recent advances in our understanding of Streptococcus pneumoniae infection.
|
|
670
|
|
|
‡a
Author's Reliable and cost-effective serodiagnosis of rheumatoid arthritis.
|
|
670
|
|
|
‡a
Author's Response
|
|
670
|
|
|
‡a
Author's Review: current and new generation pneumococcal vaccines
|
|
670
|
|
|
‡a
Author's Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia.
|
|
670
|
|
|
‡a
Author's Riminophenazine compounds: pharmacology and anti-neoplastic potential.
|
|
670
|
|
|
‡a
Author's Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro
|
|
670
|
|
|
‡a
Author's Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.
|
|
670
|
|
|
‡a
Author's Smoking and Air Pollution as Pro-Inflammatory Triggers for the Development of Rheumatoid Arthritis.
|
|
670
|
|
|
‡a
Author's Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study
|
|
670
|
|
|
‡a
Author's Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes
|
|
670
|
|
|
‡a
Author's Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes
|
|
670
|
|
|
‡a
Author's Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers
|
|
670
|
|
|
‡a
Author's The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium
|
|
670
|
|
|
‡a
Author's The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.
|
|
670
|
|
|
‡a
Author's The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
|
|
670
|
|
|
‡a
Author's The effect of ten phenazine-derivatives in comparison to clofazimine on the production of prostaglandin E2 by polymorphonuclear leucocytes
|
|
670
|
|
|
‡a
Author's The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation.
|
|
670
|
|
|
‡a
Author's The effects of ketoconazole on cellular and humoral immune functions
|
|
670
|
|
|
‡a
Author's The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro.
|
|
670
|
|
|
‡a
Author's The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro.
|
|
670
|
|
|
‡a
Author's The immunopharmacology of antileprosy agents
|
|
670
|
|
|
‡a
Author's The in vitro and in vivo effects of clofazimine on the motility of neutrophils and transformation of lymphocytes from normal individuals
|
|
670
|
|
|
‡a
Author's The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism
|
|
670
|
|
|
‡a
Author's The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa
|
|
670
|
|
|
‡a
Author's The pro-oxidative riminophenazine B669 neutralizes the inhibitory effects of Mycobacterium tuberculosis on phagocyte antimicrobial activity.
|
|
670
|
|
|
‡a
Author's The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line
|
|
670
|
|
|
‡a
Author's The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection
|
|
670
|
|
|
‡a
Author's The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia.
|
|
670
|
|
|
‡a
Author's The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
|
|
670
|
|
|
‡a
Author's Therapy for pneumococcal bacteremia: monotherapy or combination therapy?
|
|
670
|
|
|
‡a
Author's Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis
|
|
670
|
|
|
‡a
Author's Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following ultramarathon running.
|
|
670
|
|
|
‡a
Author's Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.
|
|
670
|
|
|
‡a
Author's Vitamin E protects mononuclear leucocyte DNA against damage mediated by phagocyte-derived oxidants
|
|
670
|
|
|
‡a
Author's Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers
|
|
670
|
|
|
‡a
Author's প্রত্যুত্তর
|
|
909
|
|
|
‡a
(orcid) 0000000259256452
‡9
1
|
|
909
|
|
|
‡a
(scopus) 7406489754
‡9
1
|
|
912
|
|
|
‡a
পরতযততর
‡A
প্রত্যুত্তর
‡9
1
|
|
912
|
|
|
‡a
response
‡A
Response
‡9
1
|
|
919
|
|
|
‡a
proteinkinase100promotesrestorationofcalciumhomeostasistoplateletactivatingfactorstimulatedhumanneutrophilsbyinhibitionofphospholipase100
‡A
Protein kinase C promotes restoration of calcium homeostasis to platelet activating factor-stimulated human neutrophils by inhibition of phospholipase C
‡9
1
|
|
919
|
|
|
‡a
proinflammatoryinteractionsofpneumolysinwithhumanneutrophils
‡A
Proinflammatory interactions of pneumolysin with human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
prooxidativeactivitiesof10phenazinederivativesrelativetothatofclofazimine
‡A
Prooxidative activities of 10 phenazine derivatives relative to that of clofazimine.
‡9
1
|
|
919
|
|
|
‡a
10yearsauditofcardiothoracicreferralsfromapulmonologyserviceinadevelopingcountryimpactofpatienthumanimmunodeficiencyvirusstatus
‡A
A 10 years audit of cardiothoracic referrals from a pulmonology service in a developing country: impact of patient human immunodeficiency virus status
‡9
1
|
|
919
|
|
|
‡a
peroxidaseindependentmethodforthequantitationofextracellularhydrogenperoxidegeneratedbyactivatedphagocytesinvitro
‡A
A peroxidase-independent method for the quantitation of extracellular hydrogen peroxide generated by activated phagocytes in vitro
‡9
1
|
|
919
|
|
|
‡a
acceleratedcalciuminfluxandhyperactivationofneutrophilsinchronicgranulomatousdisease
‡A
Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease
‡9
1
|
|
919
|
|
|
‡a
activationofhumanneutrophilswithchemotacticpeptideopsonizedzymosanandthecalciumionophorea23187butnotwithaphorbolesterisaccompaniedbyeffluxandstoreoperatedinfluxofcalcium
‡A
Activation of human neutrophils with chemotactic peptide, opsonized zymosan and the calcium ionophore A23187, but not with a phorbol ester, is accompanied by efflux and store-operated influx of calcium
‡9
1
|
|
919
|
|
|
‡a
activationofneutrophilmembraneassociatedoxidativemetabolismbyultravioletradiation
‡A
Activation of neutrophil membrane-associated oxidative metabolism by ultraviolet radiation.
‡9
1
|
|
919
|
|
|
‡a
acutephaseproteinsandstresshormoneresponsesinpatientswithnewlydiagnosedactivepulmonarytuberculosis
‡A
Acute phase proteins and stress hormone responses in patients with newly diagnosed active pulmonary tuberculosis.
‡9
1
|
|
919
|
|
|
‡a
adpmediatedupregulationofexpressionofcd62ponhumanplateletsiscriticallydependentoncoactivationofp2y1andp2y12receptors
‡A
ADP-Mediated Upregulation of Expression of CD62P on Human Platelets Is Critically Dependent on Co-Activation of P2Y1 and P2Y12 Receptors
‡9
1
|
|
919
|
|
|
‡a
Alpha tocopherolantagonizesthemultidrugresistancereversalactivityofcyclosporinaverapamilgf120918clofazimineandb669
‡A
Alpha-tocopherol antagonizes the multidrug-resistance-reversal activity of cyclosporin A, verapamil, GF120918, clofazimine and B669.
‡9
1
|
|
919
|
|
|
‡a
invitroassessmentofcertaincellularandhumoralimmunefunctionsinpatientswithchronicacneimprovedleukocytefunctionandmoderateclinicalimprovementfollowingpropranololtherapyinanuncontrolledtrial
‡A
An in vitro assessment of certain cellular and humoral immune functions in patients with chronic acne. Improved leukocyte function and moderate clinical improvement following propranolol therapy in an uncontrolled trial
‡9
1
|
|
919
|
|
|
‡a
invitrocomparisonoftheeffectsoftheprooxidativeriminophenazinesclofazimineandb669onneutrophilphospholipasea2activityandsuperoxidegeneration
‡A
An in vitro comparison of the effects of the prooxidative riminophenazines clofazimine and B669 on neutrophil phospholipase A2 activity and superoxide generation
‡9
1
|
|
919
|
|
|
‡a
invitroevaluationofthecellularuptakeandintraphagocyticbioactivityofclarithromycina56268te031anewmacrolideantimicrobialagent
‡A
An in-vitro evaluation of the cellular uptake and intraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agent
‡9
1
|
|
919
|
|
|
‡a
invitroinvestigationofthebioactivitiesofciprofloxacinandthenewfluoroquinoloneagentsclinafloxacin
‡A
An in vitro investigation of the bioactivities of ciprofloxacin and the new fluoroquinolone agents clinafloxacin
‡9
1
|
|
919
|
|
|
‡a
invitroinvestigationofthebioactivitiesofciprofloxacinandthenewfluoroquinoloneagentsclinafloxacin101960andpd131628againstmycobacteriumtuberculosisinhumanmacrophages
‡A
An in vitro investigation of the bioactivities of ciprofloxacin and the new fluoroquinolone agents clinafloxacin (CI-960) and PD 131628 against Mycobacterium tuberculosis in human macrophages.
‡9
1
|
|
919
|
|
|
‡a
invitroinvestigationoftheintracellularbioactivityofamoxicillinclindamycinanderythromycinforstaphylococcusaureus
‡A
An in vitro investigation of the intracellular bioactivity of amoxicillin, clindamycin, and erythromycin for Staphylococcus aureus
‡9
1
|
|
919
|
|
|
‡a
invitroinvestigationoftheintraphagocyticbioactivityofdifloxacinciprofloxacinpefloxacinandfleroxacin
‡A
An in vitro investigation of the intraphagocytic bioactivity of difloxacin, ciprofloxacin, pefloxacin and fleroxacin
‡9
1
|
|
919
|
|
|
‡a
invivoandinvitroinvestigationofthephototoxicpotentialoftenoxicamanewnonsteroidalantiinflammatoryagent
‡A
An in vivo and in vitro investigation of the phototoxic potential of tenoxicam, a new non-steroidal anti-inflammatory agent
‡9
1
|
|
919
|
|
|
‡a
objectivefilterbasedenzymaticmethodfortheinvivomeasurementofthemigrationofhumanpolymorphonuclearleucocytes
‡A
An objective filter-based, enzymatic method for the in vivo measurement of the migration of human polymorphonuclear leucocytes
‡9
1
|
|
919
|
|
|
‡a
antioxidativeeffectsoftheophyllineonhumanneutrophilsinvolvecyclicnucleotidesandproteinkinasea
‡A
Anti-oxidative effects of theophylline on human neutrophils involve cyclic nucleotides and protein kinase A.
‡9
1
|
|
919
|
|
|
‡a
antibioticresistanceofpathogenscausingcommunityacquiredpneumonia
‡A
Antibiotic resistance of pathogens causing community-acquired pneumonia.
‡9
1
|
|
919
|
|
|
‡a
antimicrobialactivitiesofclofazimineandb669aremediatedbylysophospholipids
‡A
Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids
‡9
1
|
|
919
|
|
|
‡a
antimicrobialactivityofclofazimineisnotdependentonmycobacterial100typephospholipases
‡A
Antimicrobial activity of clofazimine is not dependent on mycobacterial C-type phospholipases.
‡9
1
|
|
919
|
|
|
‡a
apparentinvolvementofphospholipasea2butnotproteinkinase100intheprooxidativeinteractionsofclofaziminewithhumanphagocytes
‡A
Apparent involvement of phospholipase A2, but not protein kinase C, in the pro-oxidative interactions of clofazimine with human phagocytes
‡9
1
|
|
919
|
|
|
‡a
apparentinvolvementofthea2asubtypeadenosinereceptorintheantiinflammatoryinteractionsofcgs21680cyclopentyladenosineandibmecawithhumanneutrophils
‡A
Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils
‡9
1
|
|
919
|
|
|
‡a
ascorbateandcysteinemediatedselectiveneutralisationofextracellularoxidantsduringnformylpeptideactivationofhumanphagocytes
‡A
Ascorbate and cysteine-mediated selective neutralisation of extracellular oxidants during N-formyl peptide activation of human phagocytes
‡9
1
|
|
919
|
|
|
‡a
ascorbicacidneutralizesreactiveoxidantsreleasedbyhyperactivephagocytesfromcigarettesmokers
‡A
Ascorbic acid neutralizes reactive oxidants released by hyperactive phagocytes from cigarette smokers.
‡9
1
|
|
919
|
|
|
‡a
augmentativeinhibitionoflymphocyteproliferationbycyclosporinacombinedwiththeriminophenazinecompoundsclofazimineandb669
‡A
Augmentative inhibition of lymphocyte proliferation by cyclosporin A combined with the riminophenazine compounds clofazimine and B669
‡9
1
|
|
919
|
|
|
‡a
bacteraemicpneumococcalpneumoniacurrenttherapeuticoptions
‡A
Bacteraemic pneumococcal pneumonia: current therapeutic options
‡9
1
|
|
919
|
|
|
‡a
bacterialrespiratoryinfectionscomplicatinghumanimmunodeficiencyvirus
‡A
Bacterial Respiratory Infections Complicating Human Immunodeficiency Virus.
‡9
1
|
|
919
|
|
|
‡a
beneficialandharmfulinteractionsofantibioticswithmicrobialpathogensandthehostinnateimmunesystem
‡A
Beneficial and Harmful Interactions of Antibiotics with Microbial Pathogens and the Host Innate Immune System
‡9
1
|
|
919
|
|
|
‡a
benoxaprofenaprooxidantantiinflammatorydrug
‡A
Benoxaprofen: a pro-oxidant anti-inflammatory drug?
‡9
1
|
|
919
|
|
|
‡a
benoxaprofenactivatesmembraneassociatedoxidativemetabolisminhumanpolymorphonuclearleucocytesbyapparentmodulationofproteinkinase100
‡A
Benoxaprofen activates membrane-associated oxidative metabolism in human polymorphonuclear leucocytes by apparent modulation of protein kinase C.
‡9
1
|
|
919
|
|
|
‡a
benoxaprofenactivationofsuppressoractivityinmononuclearleucocytesbyaprooxidativemechanisminvitro
‡A
Benoxaprofen activation of suppressor activity in mononuclear leucocytes by a pro-oxidative mechanism in vitro
‡9
1
|
|
919
|
|
|
‡a
biochemicalmechanismsofhydrogenperoxideandhypochlorousacidmediatedinhibitionofhumanmononuclearleukocytefunctionsinvitroprotectionandreversalbyantioxidants
‡A
Biochemical mechanisms of hydrogen peroxide- and hypochlorous acid-mediated inhibition of human mononuclear leukocyte functions in vitro: protection and reversal by anti-oxidants.
‡9
1
|
|
919
|
|
|
‡a
calciumdependentpotentiationoftheproinflammatoryfunctionsofhumanneutrophilsbytigecyclineinvitro
‡A
Calcium-dependent potentiation of the pro-inflammatory functions of human neutrophils by tigecycline in vitro
‡9
1
|
|
919
|
|
|
‡a
cantheantiinflammatoryactivitiesofβ2agonistsbeharnessedintheclinicalsetting
‡A
Can the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?
‡9
1
|
|
919
|
|
|
‡a
cardiactroponintasapredictorofshortandlongtermmortalityincommunityacquiredpneumonia
‡A
Cardiac troponin T as a predictor of short- and long-term mortality in community-acquired pneumonia
‡9
1
|
|
919
|
|
|
‡a
cgs21680dibutyrylcyclicampandrolipramattenuatetheproinflammatoryinteractionsofthepseudomonasaeruginosaderivedpigment1hydroxyphenazinewithhumanneutrophils
‡A
CGS 21680, dibutyryl cyclic AMP and rolipram attenuate the pro-inflammatory interactions of the Pseudomonas aeruginosa -derived pigment, 1-hydroxyphenazine, with human neutrophils
‡9
1
|
|
919
|
|
|
‡a
changesinneutrophilmotilityaccompanyingdapsoneandrifampicintherapy
‡A
Changes in neutrophil motility accompanying dapsone and rifampicin therapy
‡9
1
|
|
919
|
|
|
‡a
changesinserumcytokinesafterrepeatedboutsofdownhillrunning
‡A
Changes in serum cytokines after repeated bouts of downhill running.
‡9
1
|
|
919
|
|
|
‡a
characterizationoftheinteractionsofthepneumolysoidδ6plywithhumanneutrophilsinvitro
‡A
Characterization of the interactions of the pneumolysoid, Δ6 PLY, with human neutrophils in vitro
‡9
1
|
|
919
|
|
|
‡a
cigarettesmokecondensateattenuatesphorbolestermediatedneutrophilextracellulartrapformation
‡A
Cigarette smoke condensate attenuates phorbol ester-mediated neutrophil extracellular trap formation
‡9
1
|
|
919
|
|
|
‡a
cigarettesmokemediatedoxidantstressphagocytesvitamin100vitamineandtissueinjury
‡A
Cigarette smoke-mediated oxidant stress, phagocytes, vitamin C, vitamin E, and tissue injury
‡9
1
|
|
919
|
|
|
‡a
cigarettesmokingandmechanismsofsusceptibilitytoinfectionsoftherespiratorytractandotherorgansystems
‡A
Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems.
‡9
1
|
|
919
|
|
|
‡a
circulatinganticitrullinatedpeptideantibodiescytokinesandgenotypeasbiomarkersofresponsetodiseasemodifyingantirheumaticdrugtherapyinearlyrheumatoidarthritis
‡A
Circulating anti-citrullinated peptide antibodies, cytokines and genotype as biomarkers of response to disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
‡9
1
|
|
919
|
|
|
‡a
circulatingbiomarkersofimmuneactivationdistinguishviralsuppressionfromnonsuppressioninhaarttreatedpatientswithadvancedhiv1subtype100infection
‡A
Circulating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infection.
‡9
1
|
|
919
|
|
|
‡a
circulatingcytokineprofilesandtheirrelationshipswithautoantibodiesacutephasereactantsanddiseaseactivityinpatientswithrheumatoidarthritis
‡A
Circulating cytokine profiles and their relationships with autoantibodies, acute phase reactants, and disease activity in patients with rheumatoid arthritis
‡9
1
|
|
919
|
|
|
‡a
clarithromycinaloneandincombinationwithceftriaxoneinhibitstheproductionofpneumolysinbybothmacrolidesusceptibleandmacrolideresistantstrainsofstreptococcuspneumoniae
‡A
Clarithromycin alone and in combination with ceftriaxone inhibits the production of pneumolysin by both macrolide-susceptible and macrolide-resistant strains of Streptococcus pneumoniae.
‡9
1
|
|
919
|
|
|
‡a
clindamycinerythromycinandroxithromycininhibittheproinflammatoryinteractionsofpseudomonasaeruginosapigmentswithhumanneutrophilsinvitro
‡A
Clindamycin, erythromycin, and roxithromycin inhibit the proinflammatory interactions of Pseudomonas aeruginosa pigments with human neutrophils in vitro
‡9
1
|
|
919
|
|
|
‡a
clofazimineandb669inhibittheproliferativeresponsesandna+k+adenosinetriphosphataseactivityofhumanlymphocytesbyalysophospholipiddependentmechanism
‡A
Clofazimine and B669 inhibit the proliferative responses and Na+, K(+)-adenosine triphosphatase activity of human lymphocytes by a lysophospholipid-dependent mechanism.
‡9
1
|
|
919
|
|
|
‡a
clofaziminemediatedregulationofhumanpolymorphonuclearleukocytemigrationbyprooxidativeinactivationofbothleukoattractantsandcellularmigratoryresponsiveness
‡A
Clofazimine-mediated regulation of human polymorphonuclear leukocyte migration by pro-oxidative inactivation of both leukoattractants and cellular migratory responsiveness
‡9
1
|
|
919
|
|
|
‡a
clofaziminemediatedstimulationofprostaglandinsynthesisandfreeradicalproductionasnovelmechanismsofdruginducedimmunosuppression
‡A
Clofazimine-mediated stimulation of prostaglandin synthesis and free radical production as novel mechanisms of drug-induced immunosuppression
‡9
1
|
|
919
|
|
|
‡a
clofaziminereversestheinhibitoryeffectofmycobacteriumtuberculosisderivedfactorsonphagocyteintracellularkillingmechanisms
‡A
Clofazimine reverses the inhibitory effect of Mycobacterium tuberculosis derived factors on phagocyte intracellular killing mechanisms.
‡9
1
|
|
919
|
|
|
‡a
communityacquiredpneumoniapathogenesisofacutecardiaceventsandpotentialadjunctivetherapies
‡A
Community-Acquired Pneumonia: Pathogenesis of Acute Cardiac Events and Potential Adjunctive Therapies
‡9
1
|
|
919
|
|
|
‡a
communityacquiredpneumoniastillamajorburdenofdisease
‡A
Community-acquired pneumonia: still a major burden of disease.
‡9
1
|
|
919
|
|
|
‡a
comparisonoftheantiinflammatoryactivitiesofimidazoleantimycoticsinrelationtomolecularstructure
‡A
Comparison of the anti-inflammatory activities of imidazole antimycotics in relation to molecular structure.
‡9
1
|
|
919
|
|
|
‡a
comparisonofthediagnosticpotentialof3anticitrullinatedproteinantibodiesasadjunctstorheumatoidfactorandccpinacohortofsouthafricanrheumatoidarthritispatients
‡A
Comparison of the diagnostic potential of three anti-citrullinated protein antibodies as adjuncts to rheumatoid factor and CCP in a cohort of South African rheumatoid arthritis patients
‡9
1
|
|
919
|
|
|
‡a
comparisonoftheeffectsofmacrolidesamoxicillinceftriaxonedoxycyclinetobramycinandfluoroquinolonesontheproductionofpneumolysinbystreptococcuspneumoniaeinvitro
‡A
Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro
‡9
1
|
|
919
|
|
|
‡a
comparisonoftheprooxidativeinteractionsofflunoxaprofenandbenoxaprofenwithhumanpolymorphonuclearleucocytesinvitro
‡A
Comparison of the pro-oxidative interactions of flunoxaprofen and benoxaprofen with human polymorphonuclear leucocytes in vitro
‡9
1
|
|
919
|
|
|
‡a
contrastingimmunopathogenicandtherapeuticrolesofgranulocytecolonystimulatingfactorincancer
‡A
Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
‡9
1
|
|
919
|
|
|
‡a
controversiesinthetreatmentofpneumococcalcommunityacquiredpneumonia
‡A
Controversies in the treatment of pneumococcal community-acquired pneumonia.
‡9
1
|
|
919
|
|
|
‡a
corticosteroidsintheadjunctivetherapyofcommunityacquiredpneumoniaanappraisalofrecentmetaanalysesofclinicaltrials
‡A
Corticosteroids in the adjunctive therapy of community-acquired pneumonia: an appraisal of recent meta-analyses of clinical trials
‡9
1
|
|
919
|
|
|
‡a
counteractingeffectsofnadphoxidaseandthena+ca2+exchangeronmembranerepolarisationandstoreoperateduptakeofca2+bychemoattractantactivatedhumanneutrophils
‡A
Counteracting effects of NADPH oxidase and the Na+/Ca2+ exchanger on membrane repolarisation and store-operated uptake of Ca2+ by chemoattractant-activated human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
cysteinylleukotrienereceptor1antagonistsasmodulatorsofinnateimmunecellfunction
‡A
Cysteinyl leukotriene receptor-1 antagonists as modulators of innate immune cell function
‡9
1
|
|
919
|
|
|
‡a
defectiveneutrophilmotilityinchildrenwithmeasles
‡A
Defective neutrophil motility in children with measles
‡9
1
|
|
919
|
|
|
‡a
depressedneutrophilmotilityinpatientswithrecurrentherpessimplexvirusinfectionsinvitrorestorationwithlevamisole
‡A
Depressed neutrophil motility in patients with recurrent herpes simplex virus infections: in vitro restoration with levamisole
‡9
1
|
|
919
|
|
|
‡a
dichloromethaneextractofdicerocaryumsenecioidesleavesexhibitsremarkableantiinflammatoryactivityinhumantlymphocytes
‡A
Dichloromethane extract of Dicerocaryum senecioides leaves exhibits remarkable anti-inflammatory activity in human T-lymphocytes.
‡9
1
|
|
919
|
|
|
‡a
differentiationofhumanmonocytesinvitrofollowingexposuretocanovaintheabsenceofcytokines
‡A
Differentiation of Human Monocytes in Vitro Following Exposure to Canova in the Absence of Cytokines
‡9
1
|
|
919
|
|
|
‡a
dithranolmediateddosedependentprimingandactivationofluminolenhancedchemiluminescenceresponsesofhumanneutrophilsinvitro
‡A
Dithranol-mediated, dose-dependent priming and activation of luminol-enhanced chemiluminescence responses of human neutrophils in vitro.
‡9
1
|
|
919
|
|
|
‡a
dithranolmediatesprooxidativeinhibitionofpolymorphonuclearleukocytemigrationandlymphocyteproliferation
‡A
Dithranol mediates pro-oxidative inhibition of polymorphonuclear leukocyte migration and lymphocyte proliferation.
‡9
1
|
|
919
|
|
|
‡a
docosahexaenoicacidandeicosapentaenoicacidantagonizetheproinflammatoryinteractionsofpneumolysinwithhumanneutrophils
‡A
Docosahexaenoic acid and eicosapentaenoic acid antagonize the proinflammatory interactions of pneumolysin with human neutrophils
‡9
1
|
|
919
|
|
|
‡a
effectofrolipramanddibutyrylcyclicamponresequestrationofcytosoliccalciuminfmlpactivatedhumanneutrophils
‡A
Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
effectofsmokingonacutephasereactantsstresshormoneresponsesandvitamin100inpulmonarytuberculosis
‡A
Effect of smoking on acute phase reactants, stress hormone responses and vitamin C in pulmonary tuberculosis.
‡9
1
|
|
919
|
|
|
‡a
effectsofbenoxaprofenonthebindingtoandinactivationofleucoattractantsbyhumanpolymorphonuclearleucocytesinvitro
‡A
Effects of benoxaprofen on the binding to and inactivation of leucoattractants by human polymorphonuclear leucocytes in vitro.
‡9
1
|
|
919
|
|
|
‡a
effectsofcigarettesmokecondensateongrowthandbiofilmformationbymycobacteriumtuberculosis
‡A
Effects of Cigarette Smoke Condensate on Growth and Biofilm Formation by Mycobacterium tuberculosis
‡9
1
|
|
919
|
|
|
‡a
effectsofcigarettesmokecondensateonpneumococcalbiofilmformationandpneumolysin
‡A
Effects of cigarette smoke condensate on pneumococcal biofilm formation and pneumolysin
‡9
1
|
|
919
|
|
|
‡a
effectsofclofaziminealoneorcombinedwithdapsoneonneutrophilandlymphocytefunctionsinnormalindividualsandpatientswithlepromatousleprosy
‡A
Effects of clofazimine alone or combined with dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy
‡9
1
|
|
919
|
|
|
‡a
effectsofclofazimineanaloguesandtumornecrosisfactor Alpha individuallyandincombinationonhumanpolymorphonuclearleukocytefunctionsinvitro
‡A
Effects of clofazimine analogues and tumor necrosis factor- Alpha individually and in combination on human polymorphonuclear leukocyte functions in vitro
‡9
1
|
|
919
|
|
|
‡a
effectsofclofazimineonplanktonicandbiofilmgrowthofmycobacteriumtuberculosisandmycobacteriumsmegmatis
‡A
Effects of clofazimine on planktonic and biofilm growth of Mycobacterium tuberculosis and Mycobacterium smegmatis.
‡9
1
|
|
919
|
|
|
‡a
effectsofclofazimineonpotassiumuptakebyatrkdeletionmutantofmycobacteriumtuberculosis
‡A
Effects of clofazimine on potassium uptake by a Trk-deletion mutant of Mycobacterium tuberculosis.
‡9
1
|
|
919
|
|
|
‡a
effectsoferythromycinoncellularandhumoralimmunefunctionsinvitroandinvivo
‡A
Effects of erythromycin on cellular and humoral immune functions in vitro and in vivo
‡9
1
|
|
919
|
|
|
‡a
effectsofsulfamethoxazoleandtrimethoprimonhumanneutrophilandlymphocytefunctionsinvitroinvivoeffectsofcotrimoxazole
‡A
Effects of sulfamethoxazole and trimethoprim on human neutrophil and lymphocyte functions in vitro: in vivo effects of co-trimoxazole.
‡9
1
|
|
919
|
|
|
‡a
effectsoftobaccousageandantiretroviraltherapyonbiomarkersofsystemicimmuneactivationinhivinfectedparticipants
‡A
Effects of Tobacco Usage and Antiretroviral Therapy on Biomarkers of Systemic Immune Activation in HIV-Infected Participants
‡9
1
|
|
919
|
|
|
‡a
endogenousadenosineregulatesneutrophilproinflammatoryactivitiesbycyclicampdependentacceleratedclearanceofcytosoliccalcium
‡A
Endogenous adenosine regulates neutrophil pro-inflammatory activities by cyclic AMP-dependent accelerated clearance of cytosolic calcium.
‡9
1
|
|
919
|
|
|
‡a
enhancedreleaseofelastaseandoxidativeinactivationof Alpha 1proteaseinhibitorbystimulatedhumanneutrophilsexposedtopseudomonasaeruginosapigment1hydroxyphenazine
‡A
Enhanced release of elastase and oxidative inactivation of Alpha -1-protease inhibitor by stimulated human neutrophils exposed to Pseudomonas aeruginosa pigment 1-hydroxyphenazine
‡9
1
|
|
919
|
|
|
‡a
enhancementbyclofazimineandinhibitionbydapsoneofproductionofprostaglandine2byhumanpolymorphonuclearleukocytesinvitro
‡A
Enhancement by clofazimine and inhibition by dapsone of production of prostaglandin E2 by human polymorphonuclear leukocytes in vitro
‡9
1
|
|
919
|
|
|
‡a
epidemiologyvirulencefactorsandmanagementofthepneumococcus
‡A
Epidemiology, virulence factors and management of the pneumococcus
‡9
1
|
|
919
|
|
|
‡a
evaluationofcirculatingsolubletriggeringreceptorexpressedonmyeloidcells1strem1topredictriskprofileresponsetoantimicrobialtherapyanddevelopmentofcomplicationsinpatientswithchemotherapyassociatedfebrileneutropeniaa
‡A
Evaluation of circulating soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) to predict risk profile, response to antimicrobial therapy, and development of complications in patients with chemotherapy-associated febrile neutropenia: a
‡9
1
|
|
919
|
|
|
‡a
exposureofa23fserotypestrainofstreptococcuspneumoniaetocigarettesmokecondensateisassociatedwithselectiveupregulationofgenesencodingthe2componentregulatorysystem11tcs11
‡A
Exposure of a 23F serotype strain of Streptococcus pneumoniae to cigarette smoke condensate is associated with selective upregulation of genes encoding the two-component regulatory system 11 (TCS11).
‡9
1
|
|
919
|
|
|
‡a
expressionofsolubletriggeringreceptorexpressedonmyeloidcells1inchildhoodcfandnoncfbronchiectasis
‡A
Expression of soluble triggering receptor expressed on myeloid cells-1 in childhood CF and non-CF bronchiectasis.
‡9
1
|
|
919
|
|
|
‡a
expressionofthegenesencodingthetrkandkdppotassiumtransportsystemsofmycobacteriumtuberculosisduringgrowthinvitro
‡A
Expression of the Genes Encoding the Trk and Kdp Potassium Transport Systems of Mycobacterium tuberculosis during Growth In Vitro
‡9
1
|
|
919
|
|
|
‡a
fattyacidbindingproteinsasbiomarkersofdiseaseseverityandoutcomeincommunityacquiredpneumonia
‡A
Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia.
‡9
1
|
|
919
|
|
|
‡a
formoterolismoreeffectivethansalmeterolinsuppressingneutrophilreactivity
‡A
Formoterol is more effective than salmeterol in suppressing neutrophil reactivity
‡9
1
|
|
919
|
|
|
‡a
functionaldisabilityandhealthrelatedqualityoflifeinsouthafricanswithearlyrheumatoidarthritis
‡A
Functional disability and health-related quality of life in South Africans with early rheumatoid arthritis.
‡9
1
|
|
919
|
|
|
‡a
furtherstudiesonerythromycineffectsoncellularimmunefunctionsinvitroandinvivoenhancementofneutrophilmotilitybyerythromycincombinedwithascorbateorthiamine
‡A
Further studies on erythromycin effects on cellular immune functions in vitro and in vivo. Enhancement of neutrophil motility by erythromycin combined with ascorbate or thiamine
‡9
1
|
|
919
|
|
|
‡a
hivassociatedbacterialpneumonia
‡A
HIV-associated bacterial pneumonia.
‡9
1
|
|
919
|
|
|
‡a
hivrelatedpneumococcaldiseasepreventioninadults
‡A
HIV-related pneumococcal disease prevention in adults.
‡9
1
|
|
919
|
|
|
‡a
hladrb1sharedepitopegenotypingusingtherevisedclassificationanditsassociationwithcirculatingautoantibodiesacutephasereactantscytokinesandclinicalindicesofdiseaseactivityinacohortofsouthafricanrheumatoidarthritispati
‡A
HLA-DRB1 shared epitope genotyping using the revised classification and its association with circulating autoantibodies, acute phase reactants, cytokines and clinical indices of disease activity in a cohort of South African rheumatoid arthritis pati
‡9
1
|
|
919
|
|
|
‡a
humanneutrophilnadphoxidaseactivityisinhibitedbylazaroids
‡A
Human neutrophil NADPH-oxidase activity is inhibited by lazaroids
‡9
1
|
|
919
|
|
|
‡a
hyaluronidaseaugmentspneumolysinmediatedinjurytohumanciliatedepithelium
‡A
Hyaluronidase augments pneumolysin-mediated injury to human ciliated epithelium.
‡9
1
|
|
919
|
|
|
‡a
hyperferritinemiaandmarkersofinflammationandoxidativestressinthecordbloodofhivexposeduninfectedheuinfants
‡A
Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants
‡9
1
|
|
919
|
|
|
‡a
hypochlorousacidpotentiateshydrogenperoxidemediateddnastrandbreaksinhumanmononuclearleucocytes
‡A
Hypochlorous acid potentiates hydrogen peroxide-mediated DNA-strand breaks in human mononuclear leucocytes
‡9
1
|
|
919
|
|
|
‡a
immunedysregulationincancerpatientsundergoingimmunecheckpointinhibitortreatmentandpotentialpredictivestrategiesforfutureclinicalpractice
‡A
Immune Dysregulation in Cancer Patients Undergoing Immune Checkpoint Inhibitor Treatment and Potential Predictive Strategies for Future Clinical Practice.
‡9
1
|
|
919
|
|
|
‡a
impactofhivinfectionandsmokingonlungimmunityandrelateddisorders
‡A
Impact of HIV infection and smoking on lung immunity and related disorders.
‡9
1
|
|
919
|
|
|
‡a
vitaminepulmonaryfunctionsandphagocytemediatedoxidativestressinsmokersandnonsmokers
‡A
Vitamin E, pulmonary functions, and phagocyte-mediated oxidative stress in smokers and nonsmokers
‡9
1
|
|
919
|
|
|
‡a
invitroandinvivoeffectsofdapsoneonneutrophilandlymphocytefunctionsinnormalindividualsandpatientswithlepromatousleprosy
‡A
In vitro and in vivo effects of dapsone on neutrophil and lymphocyte functions in normal individuals and patients with lepromatous leprosy
‡9
1
|
|
919
|
|
|
‡a
invitroinvestigationoftheintraphagocyticbioactivitiesofciprofloxacinandthenewfluoroquinoloneagentsclinafloxacin101960andpd131628
‡A
In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.
‡9
1
|
|
919
|
|
|
‡a
invitrostimulationofneutrophilmotilitybymetoprololandsotalolrelatedtoinhibitionofbothh2o2productionandperoxidasemediatediodinationofthecellandleucoattractant
‡A
In vitro stimulation of neutrophil motility by metoprolol and sotalol related to inhibition of both H2O2 production and peroxidase mediated iodination of the cell and leucoattractant
‡9
1
|
|
919
|
|
|
‡a
invivoeffectsofpropranololonsomecellularandhumoralimmunefunctionsinagroupofpatientswithlepromatousleprosy
‡A
In vivo effects of propranolol on some cellular and humoral immune functions in a group of patients with lepromatous leprosy
‡9
1
|
|
919
|
|
|
‡a
inactivationofpoly
‡A
Inactivation of poly
‡9
1
|
|
919
|
|
|
‡a
inactivationofpolyadpribosepolymerasebyhypochlorousacid
‡A
Inactivation of poly (ADP-ribose) polymerase by hypochlorous acid
‡9
1
|
|
919
|
|
|
‡a
increasedfrequencyofoxidantmediateddnastrandbreaksinmononuclearleucocytesexposedtoactivatedneutrophilsfromcigarettesmokers
‡A
Increased frequency of oxidant-mediated DNA strand breaks in mononuclear leucocytes exposed to activated neutrophils from cigarette smokers.
‡9
1
|
|
919
|
|
|
‡a
increasedlevelsofautoantibodiestocardiolipinandoxidisedlowdensitylipoproteinareinverselyassociatedwithplasmavitamin100statusincigarettesmokers
‡A
Increased levels of autoantibodies to cardiolipin and oxidised low density lipoprotein are inversely associated with plasma vitamin C status in cigarette smokers
‡9
1
|
|
919
|
|
|
‡a
influenceofantimicrobialchemotherapyonspirometricparametersandproinflammatoryindicesinseverepulmonarytuberculosis
‡A
Influence of antimicrobial chemotherapy on spirometric parameters and pro-inflammatory indices in severe pulmonary tuberculosis.
‡9
1
|
|
919
|
|
|
‡a
inhaledmicroparticlescontainingclofazimineareefficaciousintreatmentofexperimentaltuberculosisinmice
‡A
Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice
‡9
1
|
|
919
|
|
|
‡a
inhibitionofmitogenactivatedproliferationofhumanlymphocytesbyhypochlorousacidinvitroprotectionandreversalbyascorbateandcysteine
‡A
Inhibition of mitogen-activated proliferation of human lymphocytes by hypochlorous acid in vitro: protection and reversal by ascorbate and cysteine
‡9
1
|
|
919
|
|
|
‡a
inhibitionofpolymorphonuclearleucocytemotilitybybenoxaprofenrelatedtoactivationofcellularoxidativemetabolism
‡A
Inhibition of polymorphonuclear leucocyte motility by benoxaprofen related to activation of cellular oxidative metabolism
‡9
1
|
|
919
|
|
|
‡a
inhibitionoftheprooxidanteffectsofbenoxaprofenonpolymorphonuclearleucocytesbyretinolacetateinvitro
‡A
Inhibition of the pro-oxidant effects of benoxaprofen on polymorphonuclear leucocytes by retinol acetate in vitro
‡9
1
|
|
919
|
|
|
‡a
vitamineprotectsmononuclearleucocytednaagainstdamagemediatedbyphagocytederivedoxidants
‡A
Vitamin E protects mononuclear leucocyte DNA against damage mediated by phagocyte-derived oxidants
‡9
1
|
|
919
|
|
|
‡a
vitamineattenuatestheinjuriouseffectsofbioactivephospholipidsonhumanciliatedepitheliuminvitro
‡A
Vitamin E attenuates the injurious effects of bioactive phospholipids on human ciliated epithelium in vitro.
‡9
1
|
|
919
|
|
|
‡a
vitamin100supplementationattenuatestheincreasesincirculatingcortisoladrenalineandantiinflammatorypolypeptidesfollowingultramarathonrunning
‡A
Vitamin C supplementation attenuates the increases in circulating cortisol, adrenaline and anti-inflammatory polypeptides following ultramarathon running.
‡9
1
|
|
919
|
|
|
‡a
tobaccoderivedlipopolysaccharidenotmicrobialtranslocationasapotentialcontributortothepathogenesisofrheumatoidarthritis
‡A
Tobacco-Derived Lipopolysaccharide, Not Microbial Translocation, as a Potential Contributor to the Pathogenesis of Rheumatoid Arthritis
‡9
1
|
|
919
|
|
|
‡a
therapyforpneumococcalbacteremiamonotherapyorcombinationtherapy
‡A
Therapy for pneumococcal bacteremia: monotherapy or combination therapy?
‡9
1
|
|
919
|
|
|
‡a
inositol145triphosphatemediatedshuttlingbetweenintracellularstoresandthecytosolcontributestothesustainedelevationincytosoliccalciuminfmlpactivatedhumanneutrophils
‡A
Inositol 1,4,5-triphosphate-mediated shuttling between intracellular stores and the cytosol contributes to the sustained elevation in cytosolic calcium in FMLP-activated human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
investigationintotherelationshipbetweencalyculinamediatedpotentiationofnadphoxidaseactivityandinhibitionofstoreoperateduptakeofcalciumbyhumanneutrophils
‡A
Investigation into the relationship between calyculin A-mediated potentiation of NADPH oxidase activity and inhibition of store-operated uptake of calcium by human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
roleoftransforminggrowthfactorbeta1intheprogressionofhivaidsanddevelopmentofnonaidsdefiningfibroticdisorders
‡A
The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders
‡9
1
|
|
919
|
|
|
‡a
roleofstreptococcuspneumoniaeincommunityacquiredpneumonia
‡A
The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia.
‡9
1
|
|
919
|
|
|
‡a
investigationoftheeffectsoforaladministrationofvitamineandbetacaroteneonthechemiluminescenceresponsesandthefrequencyofsisterchromatidexchangesincirculatingleukocytesfromcigarettesmokers
‡A
Investigation of the effects of oral administration of vitamin E and beta-carotene on the chemiluminescence responses and the frequency of sister chromatid exchanges in circulating leukocytes from cigarette smokers.
‡9
1
|
|
919
|
|
|
‡a
investigationoftheinvitrouptakeintraphagocyticbiologicalactivityandeffectsonneutrophilsuperoxidegenerationofdirithromycincomparedwitherythromycin
‡A
Investigation of the in-vitro uptake, intraphagocytic biological activity and effects on neutrophil superoxide generation of dirithromycin compared with erythromycin
‡9
1
|
|
919
|
|
|
‡a
roleofpneumolysininthepathogenesisofstreptococcuspneumoniaeinfection
‡A
The role of pneumolysin in the pathogenesis of Streptococcus pneumoniae infection
‡9
1
|
|
919
|
|
|
‡a
riminophenazineagentsclofazimineandb669reverseacquiredmultidrugresistanceinahumanlungcancercellline
‡A
The riminophenazine agents clofazimine and B669 reverse acquired multidrug resistance in a human lung cancer cell line
‡9
1
|
|
919
|
|
|
‡a
prooxidativeriminophenazineb669neutralizestheinhibitoryeffectsofmycobacteriumtuberculosisonphagocyteantimicrobialactivity
‡A
The pro-oxidative riminophenazine B669 neutralizes the inhibitory effects of Mycobacterium tuberculosis on phagocyte antimicrobial activity.
‡9
1
|
|
919
|
|
|
‡a
prevalenceofsmokingandtheknowledgeofsmokinghazardsandsmokingcessationstrategiesamonghivpositivepatientsinjohannesburgsouthafrica
‡A
The prevalence of smoking and the knowledge of smoking hazards and smoking cessation strategies among HIV- positive patients in Johannesburg, South Africa
‡9
1
|
|
919
|
|
|
‡a
ketolideantimicrobialagenthmr3004inhibitsneutrophilsuperoxideproductionbyamembranestabilizingmechanism
‡A
The ketolide antimicrobial agent HMR-3004 inhibits neutrophil superoxide production by a membrane-stabilizing mechanism
‡9
1
|
|
919
|
|
|
‡a
invitroandinvivoeffectsofclofazimineonthemotilityofneutrophilsandtransformationoflymphocytesfromnormalindividuals
‡A
The in vitro and in vivo effects of clofazimine on the motility of neutrophils and transformation of lymphocytes from normal individuals
‡9
1
|
|
919
|
|
|
‡a
immunopharmacologyofantileprosyagents
‡A
The immunopharmacology of antileprosy agents
‡9
1
|
|
919
|
|
|
‡a
effectsofpneumolysinandhydrogenperoxidealoneandincombinationonhumanciliatedepitheliuminvitro
‡A
The effects of pneumolysin and hydrogen peroxide, alone and in combination, on human ciliated epithelium in vitro.
‡9
1
|
|
919
|
|
|
‡a
effectsofketolidesonbioactivephospholipidinducedinjurytohumanrespiratoryepitheliuminvitro
‡A
The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro.
‡9
1
|
|
919
|
|
|
‡a
effectsofketoconazoleoncellularandhumoralimmunefunctions
‡A
The effects of ketoconazole on cellular and humoral immune functions
‡9
1
|
|
919
|
|
|
‡a
effectsofdabigatranandrivaroxabanonmarkersofpolymorphonuclearleukocyteactivation
‡A
The Effects of Dabigatran and Rivaroxaban on Markers of Polymorphonuclear Leukocyte Activation.
‡9
1
|
|
919
|
|
|
‡a
investigationoftherelationshipsbetweenplasmalevelsofascorbatevitamineandbetacaroteneandthefrequencyofsisterchromatidexchangesandreleaseofreactiveoxidantsbybloodleucocytesfromcigarettesmokers
‡A
Investigation of the relationships between plasma levels of ascorbate, vitamin E and beta-carotene and the frequency of sister-chromatid exchanges and release of reactive oxidants by blood leucocytes from cigarette smokers
‡9
1
|
|
919
|
|
|
‡a
investigationofthestructuralpropertiesofdihydrophenazineswhichcontributetotheirprooxidativeinteractionswithhumanphagocytes
‡A
Investigation of the structural properties of dihydrophenazines which contribute to their pro-oxidative interactions with human phagocytes.
‡9
1
|
|
919
|
|
|
‡a
itraconazoleantagonizesstoreoperatedinfluxofcalciumintochemoattractantactivatedhumanneutrophils
‡A
Itraconazole antagonizes store-operated influx of calcium into chemoattractant-activated human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
itraconazolemediatedinhibitionofcalciumentryintoplateletactivatingfactorstimulatedhumanneutrophilsisduetointerferencewithproductionofleukotrieneb4
‡A
Itraconazole-mediated inhibition of calcium entry into platelet-activating factor-stimulated human neutrophils is due to interference with production of leukotriene B4
‡9
1
|
|
919
|
|
|
‡a
leucocytefunctioninchildrenwithkwashiorkor
‡A
Leucocyte function in children with kwashiorkor
‡9
1
|
|
919
|
|
|
‡a
manganesepromotesincreasedformationofhydrogenperoxidebyactivatedhumanmacrophagesandneutrophilsinvitro
‡A
Manganese promotes increased formation of hydrogen peroxide by activated human macrophages and neutrophils in vitro
‡9
1
|
|
919
|
|
|
‡a
mechanismsofactionandtherapeuticefficaciesofthelipophilicantimycobacterialagentsclofazimineandbedaquiline
‡A
Mechanisms of action and therapeutic efficacies of the lipophilic antimycobacterial agents clofazimine and bedaquiline
‡9
1
|
|
919
|
|
|
‡a
membranestabilizingantiinflammatoryinteractionsofmacrolideswithhumanneutrophils
‡A
Membrane-stabilizing, anti-inflammatory interactions of macrolides with human neutrophils
‡9
1
|
|
919
|
|
|
‡a
membranestabilizingantioxidativeinteractionsofpropranololanddexpropranololwithneutrophils
‡A
Membrane stabilizing, anti-oxidative interactions of propranolol and dexpropranolol with neutrophils.
‡9
1
|
|
919
|
|
|
‡a
montelukastmorethanacysteinylleukotrienereceptorantagonist
‡A
Montelukast: more than a cysteinyl leukotriene receptor antagonist?
‡9
1
|
|
919
|
|
|
‡a
multifacetedroleofpneumolysininthepathogenesisofmyocardialinjuryincommunityacquiredpneumonia
‡A
Multifaceted Role of Pneumolysin in the Pathogenesis of Myocardial Injury in Community-Acquired Pneumonia.
‡9
1
|
|
919
|
|
|
‡a
nadphoxidaseactivityofstimulatedneutrophilsismarkedlyincreasedbyserum
‡A
NADPH-oxidase activity of stimulated neutrophils is markedly increased by serum
‡9
1
|
|
919
|
|
|
‡a
neutrophilspotentiateplatinummediatedinjurytohumanciliatedepitheliuminvitro
‡A
Neutrophils potentiate platinum-mediated injury to human ciliated epithelium in vitro
‡9
1
|
|
919
|
|
|
‡a
newinsightsintopneumococcaldisease
‡A
New insights into pneumococcal disease.
‡9
1
|
|
919
|
|
|
‡a
noveltetramethylpiperidinesubstitutedphenazinesarepotentinhibitorsofpglycoproteinactivityinamultidrugresistantcancercellline
‡A
Novel tetramethylpiperidine-substituted phenazines are potent inhibitors of P-glycoprotein activity in a multidrug resistant cancer cell line.
‡9
1
|
|
919
|
|
|
‡a
overviewofcommunityacquiredpneumoniaandtheroleofinflammatorymechanismsintheimmunopathogenesisofseverepneumococcaldisease
‡A
Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease.
‡9
1
|
|
919
|
|
|
‡a
oxidantmediatedciliarydysfunctioninhumanrespiratoryepithelium
‡A
Oxidant-mediated ciliary dysfunction in human respiratory epithelium
‡9
1
|
|
919
|
|
|
‡a
oxidativeinductionofproinflammatorycytokineformationbyhumanmonocytederivedmacrophagesfollowingexposuretomanganeseinvitro
‡A
Oxidative induction of pro-inflammatory cytokine formation by human monocyte-derived macrophages following exposure to manganese in vitro.
‡9
1
|
|
919
|
|
|
‡a
oxidativeinhibitionofpolymorphonuclearleukocytemotilitymediatedbytheperoxidaseh2o2halidesystemstudiesonthereversiblenatureoftheinhibitionandmechanismofprotectionofmigratoryresponsivenessbyascorbatelevamisolethiamine
‡A
Oxidative inhibition of polymorphonuclear leukocyte motility mediated by the peroxidase/H2O2/halide system: studies on the reversible nature of the inhibition and mechanism of protection of migratory responsiveness by ascorbate, levamisole, thiamine
‡9
1
|
|
919
|
|
|
‡a
palladiumattenuatestheproinflammatoryinteractionsofc5ainterleukin8andpneumolysinwithhumanneutrophils
‡A
Palladium attenuates the pro-inflammatory interactions of C5a, interleukin-8 and pneumolysin with human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
pathogenandhostdirectedantiinflammatoryactivitiesofmacrolideantibiotics
‡A
Pathogen- and host-directed anti-inflammatory activities of macrolide antibiotics
‡9
1
|
|
919
|
|
|
‡a
pharmacologicalapproachestoregulateneutrophilactivity
‡A
Pharmacological approaches to regulate neutrophil activity.
‡9
1
|
|
919
|
|
|
‡a
pitfallsintheassessmentofsmokingstatusdetectedinacohortofsouthafricanrapatients
‡A
Pitfalls in the assessment of smoking status detected in a cohort of South African RA patients.
‡9
1
|
|
919
|
|
|
‡a
plasmalevelsofbetacaroteneareinverselycorrelatedwithcirculatingneutrophilcountsinyoungmalecigarettesmokers
‡A
Plasma levels of beta-carotene are inversely correlated with circulating neutrophil counts in young male cigarette smokers
‡9
1
|
|
919
|
|
|
‡a
plateletactivatingfactorandlysopafpossessdirectantimicrobialpropertiesinvitro
‡A
Platelet-activating factor and lyso-PAF possess direct antimicrobial properties in vitro
‡9
1
|
|
919
|
|
|
‡a
pneumolysinactivatesneutrophilextracellulartrapformation
‡A
Pneumolysin activates neutrophil extracellular trap formation
‡9
1
|
|
919
|
|
|
‡a
pneumolysinactivatesthesynthesisandreleaseofinterleukin8byhumanneutrophilsinvitro
‡A
Pneumolysin activates the synthesis and release of interleukin-8 by human neutrophils in vitro.
‡9
1
|
|
919
|
|
|
‡a
pneumolysinasapotentialtherapeutictargetinseverepneumococcaldisease
‡A
Pneumolysin as a potential therapeutic target in severe pneumococcal disease.
‡9
1
|
|
919
|
|
|
‡a
pneumolysininducesreleaseofmatrixmetalloproteinase8and9fromhumanneutrophils
‡A
Pneumolysin induces release of matrix metalloproteinase-8 and -9 from human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
pneumolysinmediatedactivationofnfkappabinhumanneutrophilsisantagonizedbydocosahexaenoicacid
‡A
Pneumolysin-mediated activation of NFkappaB in human neutrophils is antagonized by docosahexaenoic acid.
‡9
1
|
|
919
|
|
|
‡a
pneumolysinmediatesheterotypicaggregationofneutrophilsandplateletsinvitro
‡A
Pneumolysin mediates heterotypic aggregation of neutrophils and platelets in vitro
‡9
1
|
|
919
|
|
|
‡a
pneumolysinmediatesplateletactivationinvitro
‡A
Pneumolysin Mediates Platelet Activation In Vitro
‡9
1
|
|
919
|
|
|
‡a
pneumolysinpotentiatesoxidativeinactivationof Alpha 1proteinaseinhibitorbyactivatedhumanneutrophils
‡A
Pneumolysin potentiates oxidative inactivation of Alpha -1-proteinase inhibitor by activated human neutrophils.
‡9
1
|
|
919
|
|
|
‡a
pneumolysinpotentiatesproductionofprostaglandine
‡A
Pneumolysin potentiates production of prostaglandin E
‡9
1
|
|
919
|
|
|
‡a
pneumolysinpotentiatesproductionofprostaglandine2andleukotrieneb4byhumanneutrophils
‡A
Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils
‡9
1
|
|
919
|
|
|
‡a
pneumoniaasasystemicillness
‡A
Pneumonia as a systemic illness.
‡9
1
|
|
919
|
|
|
‡a
posaconazoleattenuatesleukotrieneb4releaseanduptakeofcalciumbychemoattractantactivatedhumanneutrophilsapotentialstrategytocontrolneutrophilmediatedinflammation
‡A
Posaconazole attenuates leukotriene B4 release and uptake of calcium by chemoattractant-activated human neutrophils: a potential strategy to control neutrophil-mediated inflammation.
‡9
1
|
|
919
|
|
|
‡a
potentiationofthegenerationofreactiveoxidantsbyhumanphagocytesduringexposuretobenoxaprofenandultravioletradiationinvitro
‡A
Potentiation of the generation of reactive oxidants by human phagocytes during exposure to benoxaprofen and ultraviolet radiation in vitro.
‡9
1
|
|
919
|
|
|
‡a
predictionofoutcomeincancerpatientswithfebrileneutropeniacomparisonofthemultinationalassociationofsupportivecareincancerriskindexscorewithprocalcitonin100reactiveproteinserumamyloidaandinterleukins1beta68and
‡A
Prediction of outcome in cancer patients with febrile neutropenia: comparison of the Multinational Association of Supportive Care in Cancer risk-index score with procalcitonin, C-reactive protein, serum amyloid A, and interleukins-1beta, -6, -8 and
‡9
1
|
|
919
|
|
|
‡a
preventionofperoxidasemediatedinhibitionofneutrophilmotilityandlymphocytetransformationbylevamisoleompisodiumaurothiomalateindomethacinandtolmetininvitro
‡A
Prevention of peroxidase mediated inhibition of neutrophil motility and lymphocyte transformation by levamisole, OMPI, sodium aurothiomalate, indomethacin and tolmetin in vitro
‡9
1
|
|
919
|
|
|
‡a
prooxidativeinteractionsofcobaltwithhumanneutrophils
‡A
Pro-oxidative interactions of cobalt with human neutrophils
‡9
1
|
|
919
|
|
|
‡a
effectof10phenazinederivativesincomparisontoclofazimineontheproductionofprostaglandine2bypolymorphonuclearleucocytes
‡A
The effect of ten phenazine-derivatives in comparison to clofazimine on the production of prostaglandin E2 by polymorphonuclear leucocytes
‡9
1
|
|
919
|
|
|
‡a
diagnosticutilityoftheanticcpantibodytestisnobetterthanrheumatoidfactorinsouthafricanswithearlyrheumatoidarthritis
‡A
The diagnostic utility of the anti-CCP antibody test is no better than rheumatoid factor in South Africans with early rheumatoid arthritis
‡9
1
|
|
919
|
|
|
‡a
beta2adrenoreceptoragonistsformoterolandindacaterolbutnotsalbutamoleffectivelysuppressthereactivityofhumanneutrophilsinvitro
‡A
The beta-2-adrenoreceptor agonists, formoterol and indacaterol, but not salbutamol, effectively suppress the reactivity of human neutrophils in vitro.
‡9
1
|
|
919
|
|
|
‡a
antiinflammatoryinteractionsofepinephrinewithhumanneutrophilsinvitroareachievedbycyclicampmediatedacceleratedresequestrationofcytosoliccalcium
‡A
The anti-inflammatory interactions of epinephrine with human neutrophils in vitro are achieved by cyclic AMP-mediated accelerated resequestration of cytosolic calcium
‡9
1
|
|
919
|
|
|
‡a
systemicimmuneactivationprofilesofhiv1subtype100infectedchildrenandtheirmothers
‡A
Systemic Immune Activation Profiles of HIV-1 Subtype C-Infected Children and Their Mothers
‡9
1
|
|
919
|
|
|
‡a
studiesontheeffectsofingestionofasingle500mgoraldoseoferythromycinstearateonleucocytemotilityandtransformationandonreleaseinvitroofprostaglandine2bystimulatedleucocytes
‡A
Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes
‡9
1
|
|
919
|
|
|
‡a
prooxidativeinteractionsofdithranolwithhumanphagocytespromoteoxidativedamagetodnaofbystanderleucocytes
‡A
Pro-oxidative interactions of dithranol with human phagocytes promote oxidative damage to DNA of bystander leucocytes
‡9
1
|
|
919
|
|
|
‡a
prognosticsignificanceoftheneutrophillymphocyteratioinpatientsundergoingtreatmentwithnivolumabforrecurrentnonsmallcelllungcancer
‡A
Prognostic significance of the neutrophil/lymphocyte ratio in patients undergoing treatment with nivolumab for recurrent non-small-cell lung cancer
‡9
1
|
|
919
|
|
|
‡a
spirometricabnormalitiesinyoungsmokerscorrelatewithincreasedchemiluminescenceresponsesofactivatedbloodphagocytes
‡A
Spirometric abnormalities in young smokers correlate with increased chemiluminescence responses of activated blood phagocytes
‡9
1
|
|
919
|
|
|
‡a
solubletriggeringreceptorexpressedonmyeloidcellsinsputumofpatientswithcommunityacquiredpneumoniaorpulmonarytuberculosisapilotstudy
‡A
Soluble triggering receptor expressed on myeloid cells in sputum of patients with community-acquired pneumonia or pulmonary tuberculosis: a pilot study
‡9
1
|
|
919
|
|
|
‡a
smokingandairpollutionasproinflammatorytriggersforthedevelopmentofrheumatoidarthritis
‡A
Smoking and Air Pollution as Pro-Inflammatory Triggers for the Development of Rheumatoid Arthritis.
‡9
1
|
|
919
|
|
|
‡a
serummatrixmetalloproteinase3incomparisonwithacutephaseproteinsasamarkerofdiseaseactivityandradiographicdamageinearlyrheumatoidarthritis
‡A
Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis.
‡9
1
|
|
919
|
|
|
‡a
roxithromycinclarithromycinandazithromycinattenuatetheinjuriouseffectsofbioactivephospholipidsonhumanrespiratoryepitheliuminvitro
‡A
Roxithromycin, clarithromycin, and azithromycin attenuate the injurious effects of bioactive phospholipids on human respiratory epithelium in vitro
‡9
1
|
|
919
|
|
|
‡a
riminophenazinecompoundspharmacologyandantineoplasticpotential
‡A
Riminophenazine compounds: pharmacology and anti-neoplastic potential.
‡9
1
|
|
919
|
|
|
‡a
reviewmanuscriptmechanismsofplateletactivationbythepneumococcusandtheroleofplateletsincommunityacquiredpneumonia
‡A
Review manuscript: Mechanisms of platelet activation by the pneumococcus and the role of platelets in community-acquired pneumonia.
‡9
1
|
|
919
|
|
|
‡a
reviewcurrentandnewgenerationpneumococcalvaccines
‡A
Review: current and new generation pneumococcal vaccines
‡9
1
|
|
919
|
|
|
‡a
reliableandcosteffectiveserodiagnosisofrheumatoidarthritis
‡A
Reliable and cost-effective serodiagnosis of rheumatoid arthritis.
‡9
1
|
|
919
|
|
|
‡a
recentadvancesinourunderstandingofstreptococcuspneumoniaeinfection
‡A
Recent advances in our understanding of Streptococcus pneumoniae infection.
‡9
1
|
|
919
|
|
|
‡a
reactiveoxidantsregulatemembranerepolarizationandstoreoperateduptakeofcalciumbyformylpeptideactivatedhumanneutrophils
‡A
Reactive oxidants regulate membrane repolarization and store-operated uptake of calcium by formyl peptide-activated human neutrophils.
‡9
1
|
|
996
|
|
|
‡2
ISNI|0000000116671018
|
|
996
|
|
|
‡2
PLWABN|9810655306905606
|
|
996
|
|
|
‡2
NTA|07104454X
|
|
996
|
|
|
‡2
BIBSYS|90532442
|
|
996
|
|
|
‡2
SUDOC|070675317
|
|
996
|
|
|
‡2
LC|nr 95007948
|
|
996
|
|
|
‡2
J9U|987007357021505171
|
|
996
|
|
|
‡2
BNF|16577375
|
|
996
|
|
|
‡2
RERO|A002928552
|
|
996
|
|
|
‡2
ISNI|0000000030465467
|
|
996
|
|
|
‡2
LC|n 85336954
|
|
996
|
|
|
‡2
NTA|074670476
|
|
996
|
|
|
‡2
LC|n 89645399
|
|
996
|
|
|
‡2
NLA|000035778604
|
|
996
|
|
|
‡2
SUDOC|113293798
|
|
996
|
|
|
‡2
J9U|987007282844905171
|
|
996
|
|
|
‡2
DBC|87097968066778
|
|
996
|
|
|
‡2
CAOONL|ncf10786961
|
|
996
|
|
|
‡2
ISNI|0000000046491459
|
|
996
|
|
|
‡2
NTA|074982915
|
|
996
|
|
|
‡2
CAOONL|ncf10786966
|
|
996
|
|
|
‡2
NTA|129457868
|
|
996
|
|
|
‡2
DNB|171950704
|
|
996
|
|
|
‡2
CAOONL|ncf10276030
|
|
996
|
|
|
‡2
BNF|16725783
|
|
996
|
|
|
‡2
LC|n 88663912
|
|
996
|
|
|
‡2
RERO|A009321513
|
|
996
|
|
|
‡2
LC|no2010184851
|
|
996
|
|
|
‡2
NII|DA02075441
|
|
996
|
|
|
‡2
J9U|987007369018505171
|
|
996
|
|
|
‡2
RERO|A002928556
|
|
996
|
|
|
‡2
RERO|A002928557
|
|
996
|
|
|
‡2
RERO|A002928554
|
|
996
|
|
|
‡2
BNE|XX929669
|
|
996
|
|
|
‡2
ISNI|0000000109592063
|
|
996
|
|
|
‡2
RERO|A002928553
|
|
996
|
|
|
‡2
RERO|A002928551
|
|
996
|
|
|
‡2
ISNI|0000000029604650
|
|
996
|
|
|
‡2
ISNI|0000000384956714
|
|
996
|
|
|
‡2
B2Q|0000819322
|
|
996
|
|
|
‡2
BIBSYS|90260052
|
|
996
|
|
|
‡2
LC|no 00091384
|
|
996
|
|
|
‡2
NTA|133613623
|
|
996
|
|
|
‡2
BIBSYS|90173325
|
|
996
|
|
|
‡2
ISNI|0000000025190294
|
|
996
|
|
|
‡2
BIBSYS|90382013
|
|
996
|
|
|
‡2
ISNI|0000000084001772
|
|
996
|
|
|
‡2
PLWABN|9813655219705606
|
|
996
|
|
|
‡2
RERO|A010999545
|
|
996
|
|
|
‡2
B2Q|0000924584
|
|
996
|
|
|
‡2
LNB|LNC10-000011464
|
|
996
|
|
|
‡2
LC|n 79138243
|
|
996
|
|
|
‡2
SUDOC|182080471
|
|
996
|
|
|
‡2
LC|no2021126873
|
|
996
|
|
|
‡2
LC|n 90671015
|
|
996
|
|
|
‡2
LC|no2019072633
|
|
996
|
|
|
‡2
LC|no2020058044
|
|
996
|
|
|
‡2
ISNI|000000045169708X
|
|
996
|
|
|
‡2
LNB|LNC10-000193503
|
|
996
|
|
|
‡2
LC|no2017163674
|
|
996
|
|
|
‡2
ISNI|000000007513248X
|
|
996
|
|
|
‡2
ISNI|0000000110745223
|
|
996
|
|
|
‡2
LC|no2008019727
|
|
996
|
|
|
‡2
NUKAT|n 2006085723
|
|
996
|
|
|
‡2
J9U|987007389030205171
|
|
996
|
|
|
‡2
LC|no2012131073
|
|
996
|
|
|
‡2
DNB|1044407808
|
|
996
|
|
|
‡2
JPG|500017270
|
|
996
|
|
|
‡2
NUKAT|n 00051032
|
|
996
|
|
|
‡2
NII|DA13947234
|
|
996
|
|
|
‡2
CAOONL|ncf11310664
|
|
996
|
|
|
‡2
NUKAT|n 2020011391
|
|
996
|
|
|
‡2
RERO|A018980598
|
|
996
|
|
|
‡2
LC|n 88624418
|
|
996
|
|
|
‡2
NUKAT|n 2014182996
|
|
996
|
|
|
‡2
LC|n 85178375
|
|
996
|
|
|
‡2
NTA|07124543X
|
|
996
|
|
|
‡2
ISNI|0000000028909495
|
|
996
|
|
|
‡2
NII|DA03525000
|
|
996
|
|
|
‡2
J9U|987012330126005171
|
|
996
|
|
|
‡2
W2Z|90173325
|
|
996
|
|
|
‡2
ISNI|0000000037020348
|
|
996
|
|
|
‡2
LC|n 95023146
|
|
996
|
|
|
‡2
J9U|987007379074305171
|
|
996
|
|
|
‡2
LC|no2002006048
|
|
996
|
|
|
‡2
LC|n 88662810
|
|
996
|
|
|
‡2
SUDOC|144387379
|
|
996
|
|
|
‡2
J9U|987007453912905171
|
|
996
|
|
|
‡2
SUDOC|16995000X
|
|
996
|
|
|
‡2
NLA|000035725433
|
|
996
|
|
|
‡2
BNF|12340303
|
|
996
|
|
|
‡2
LC|n 82034532
|
|
996
|
|
|
‡2
NSK|000237465
|
|
996
|
|
|
‡2
LC|n 85022829
|
|
996
|
|
|
‡2
LC|n 2003113053
|
|
996
|
|
|
‡2
LC|n 2011062251
|
|
996
|
|
|
‡2
LC|n 89656077
|
|
996
|
|
|
‡2
ISNI|0000000031794211
|
|
996
|
|
|
‡2
ISNI|0000000119287636
|
|
996
|
|
|
‡2
LC|no2015023592
|
|
996
|
|
|
‡2
CAOONL|ncf11242495
|
|
996
|
|
|
‡2
ISNI|0000000081022332
|
|
996
|
|
|
‡2
LC|n 2002074058
|
|
996
|
|
|
‡2
SZ|1044407808
|
|
996
|
|
|
‡2
NTA|126219931
|
|
996
|
|
|
‡2
LC|no2002006054
|
|
996
|
|
|
‡2
LIH|LNB:C9Y_g_;=B_i_
|
|
996
|
|
|
‡2
BNF|15507812
|
|
996
|
|
|
‡2
LC|n 88015915
|
|
996
|
|
|
‡2
BIBSYS|90841602
|
|
996
|
|
|
‡2
BIBSYS|90509000
|
|
996
|
|
|
‡2
BIBSYS|98004637
|
|
996
|
|
|
‡2
LC|n 79083540
|
|
996
|
|
|
‡2
NLA|000035801280
|
|
996
|
|
|
‡2
LC|n 82090560
|
|
996
|
|
|
‡2
SUDOC|184583306
|
|
996
|
|
|
‡2
CAOONL|ncf11186160
|
|
996
|
|
|
‡2
LIH|LNB:C_y_0N;=B_g_
|
|
996
|
|
|
‡2
J9U|987007335936305171
|
|
996
|
|
|
‡2
NUKAT|n 2017169141
|
|
996
|
|
|
‡2
CAOONL|ncf11194712
|
|
996
|
|
|
‡2
SUDOC|260247375
|
|
996
|
|
|
‡2
J9U|987007371979405171
|
|
996
|
|
|
‡2
PLWABN|9810610136405606
|
|
996
|
|
|
‡2
BIBSYS|13010634
|
|
996
|
|
|
‡2
JPG|500490411
|
|
996
|
|
|
‡2
DNB|171685822
|
|
996
|
|
|
‡2
LC|n 88621034
|
|
996
|
|
|
‡2
LC|no2012063754
|
|
996
|
|
|
‡2
LC|n 88666411
|
|
996
|
|
|
‡2
BNE|XX1155329
|
|
996
|
|
|
‡2
LC|n 82007589
|
|
996
|
|
|
‡2
RERO|A002928501
|
|
996
|
|
|
‡2
ISNI|0000000356152356
|
|
996
|
|
|
‡2
NUKAT|n 2013230682
|
|
996
|
|
|
‡2
SUDOC|082093652
|
|
996
|
|
|
‡2
ISNI|0000000031326952
|
|
996
|
|
|
‡2
LC|no2008157855
|
|
996
|
|
|
‡2
BIBSYS|90092236
|
|
996
|
|
|
‡2
W2Z|13010634
|
|
996
|
|
|
‡2
LC|n 87811546
|
|
996
|
|
|
‡2
LC|n 2001128721
|
|
996
|
|
|
‡2
NDL|01054516
|
|
996
|
|
|
‡2
LC|n 84164250
|
|
996
|
|
|
‡2
LC|n 2003079572
|
|
996
|
|
|
‡2
BNF|13475349
|
|
996
|
|
|
‡2
DNB|124931499
|
|
996
|
|
|
‡2
NUKAT|n 2004001455
|
|
996
|
|
|
‡2
LC|n 80162669
|
|
996
|
|
|
‡2
LC|n 85249835
|
|
996
|
|
|
‡2
NTA|099263661
|
|
996
|
|
|
‡2
BNF|15340056
|
|
996
|
|
|
‡2
LIH|LNB:C_a__e_7;=B_g_
|
|
996
|
|
|
‡2
BIBSYS|1047353
|
|
996
|
|
|
‡2
LIH|LNB:B3_b_I;=BG
|
|
996
|
|
|
‡2
NUKAT|n 2021000108
|
|
996
|
|
|
‡2
J9U|987007342646005171
|
|
996
|
|
|
‡2
CAOONL|ncf10225183
|
|
996
|
|
|
‡2
ISNI|0000000116883838
|
|
996
|
|
|
‡2
ISNI|0000000373285564
|
|
996
|
|
|
‡2
SUDOC|111119294
|
|
996
|
|
|
‡2
SUDOC|257630120
|
|
996
|
|
|
‡2
SUDOC|085957461
|
|
996
|
|
|
‡2
ISNI|0000000074942018
|
|
996
|
|
|
‡2
LC|no 96055022
|
|
996
|
|
|
‡2
J9U|987007452880105171
|
|
996
|
|
|
‡2
ISNI|0000000109850915
|
|
996
|
|
|
‡2
ISNI|0000000084847188
|
|
996
|
|
|
‡2
DNB|1018081526
|
|
996
|
|
|
‡2
DNB|1147229678
|
|
996
|
|
|
‡2
LC|n 81052209
|
|
996
|
|
|
‡2
J9U|987007423717305171
|
|
996
|
|
|
‡2
ISNI|0000000038759849
|
|
996
|
|
|
‡2
DBC|87097990066714
|
|
996
|
|
|
‡2
RERO|A002928555
|
|
996
|
|
|
‡2
LC|n 84040139
|
|
996
|
|
|
‡2
N6I|vtls000028201
|
|
996
|
|
|
‡2
SUDOC|197882595
|
|
996
|
|
|
‡2
NII|DA00666425
|
|
996
|
|
|
‡2
CAOONL|ncf10058884
|
|
996
|
|
|
‡2
LC|n 50021517
|
|
996
|
|
|
‡2
NII|DA02472510
|
|
996
|
|
|
‡2
BIBSYS|90095755
|
|
996
|
|
|
‡2
J9U|987007463443905171
|
|
996
|
|
|
‡2
BIBSYS|90524870
|
|
996
|
|
|
‡2
BNE|XX1145652
|
|
996
|
|
|
‡2
ISNI|0000000066464191
|
|
996
|
|
|
‡2
LC|n 95802684
|
|
996
|
|
|
‡2
NTA|299336565
|
|
996
|
|
|
‡2
J9U|987007440904305171
|
|
996
|
|
|
‡2
LC|no2014148434
|
|
996
|
|
|
‡2
NKC|jn20010602132
|
|
996
|
|
|
‡2
J9U|987012412352305171
|
|
996
|
|
|
‡2
BIBSYS|90373368
|
|
996
|
|
|
‡2
J9U|987007387718405171
|
|
996
|
|
|
‡2
LC|n 90681067
|
|
996
|
|
|
‡2
SIMACOB|14308451
|
|
996
|
|
|
‡2
NII|DA01404821
|
|
996
|
|
|
‡2
J9U|987007338043405171
|
|
996
|
|
|
‡2
RERO|A002928500
|
|
996
|
|
|
‡2
LC|n 92039359
|
|
996
|
|
|
‡2
NII|DA11865627
|
|
996
|
|
|
‡2
RERO|A012417997
|
|
996
|
|
|
‡2
LC|nb2011015969
|
|
996
|
|
|
‡2
ISNI|0000000408285426
|
|
996
|
|
|
‡2
DBC|87097969365094
|
|
996
|
|
|
‡2
SUDOC|061335053
|
|
996
|
|
|
‡2
LC|nb2006012556
|
|
996
|
|
|
‡2
LC|nb2015008929
|
|
996
|
|
|
‡2
SUDOC|272974137
|
|
996
|
|
|
‡2
LC|n 84041242
|
|
996
|
|
|
‡2
ISNI|000000006656781X
|
|
996
|
|
|
‡2
BIBSYS|90280869
|
|
996
|
|
|
‡2
LC|n 82241143
|
|
996
|
|
|
‡2
ISNI|0000000026965231
|
|
996
|
|
|
‡2
LC|no2008154080
|
|
996
|
|
|
‡2
ISNI|000000008255789X
|
|
996
|
|
|
‡2
PLWABN|9810632154805606
|
|
996
|
|
|
‡2
BIBSYS|90200826
|
|
996
|
|
|
‡2
NII|DA06435196
|
|
996
|
|
|
‡2
ISNI|0000000451731997
|
|
996
|
|
|
‡2
BIBSYS|90542000
|
|
996
|
|
|
‡2
J9U|987007381772305171
|
|
996
|
|
|
‡2
LC|no2014037281
|
|
996
|
|
|
‡2
ISNI|0000000067581269
|
|
996
|
|
|
‡2
BIBSYS|9060012
|
|
996
|
|
|
‡2
SUDOC|243754876
|
|
996
|
|
|
‡2
ISNI|000000012081857X
|
|
996
|
|
|
‡2
N6I|vtls002301383
|
|
996
|
|
|
‡2
J9U|987007357492905171
|
|
996
|
|
|
‡2
J9U|987007335283805171
|
|
996
|
|
|
‡2
J9U|987008913719905171
|
|
996
|
|
|
‡2
BIBSYS|90275004
|
|
996
|
|
|
‡2
DNB|121384231X
|
|
996
|
|
|
‡2
SELIBR|296856
|
|
996
|
|
|
‡2
SUDOC|070481512
|
|
996
|
|
|
‡2
NUKAT|n 96002588
|
|
996
|
|
|
‡2
LC|no2003001312
|
|
996
|
|
|
‡2
J9U|987007317242405171
|
|
996
|
|
|
‡2
BNF|14602765
|
|
996
|
|
|
‡2
ISNI|0000000026579197
|
|
996
|
|
|
‡2
CAOONL|ncf11252924
|
|
996
|
|
|
‡2
ISNI|0000000029189960
|
|
996
|
|
|
‡2
BNF|14545196
|
|
996
|
|
|
‡2
NII|DA06032961
|
|
996
|
|
|
‡2
BIBSYS|7075672
|
|
996
|
|
|
‡2
SUDOC|079711790
|
|
996
|
|
|
‡2
NDL|00511714
|
|
996
|
|
|
‡2
ISNI|0000000373820897
|
|
996
|
|
|
‡2
ISNI|0000000116875184
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
